8% L-Mandelic Serum
$42.00
Description
8% L-Mandelic Serum
8% L-Mandelic Serum is an alpha hydroxy acid serum that contains the chirally correct versions of both l-mandelic acid and l-lactic acid. L-mandelic acid has a larger molecular weight than other alpha hydroxy acids slowing down epidermal penetration resulting in a more even exfoliation with less irritation. This water-based serum is recommended for skin prone to inflamed acne, noninflamed acne, fungal folliculitis, and hyperpigmentation. It is appropriate for all skin types and is the first choice to test for skin sensitivity when adding a serum to a client’s home care routine. It is also recommended for skin that needs a boost up from 5% L-Mandelic Serum. Always perform a skin sensitivity test with this serum before adding it to a client’s home care routine.
L-Mandelic Serum Key ingredients:
8% l-mandelic acid: Alpha hydroxy acid that has anti-inflammatory, antibacterial, and anti-fungal properties, improves the appearance of pigmentation;
4% l-lactic acid: Alpha hydroxy acid that is hydrating, exfoliating, and reduces pigmentation;
Sodium hyaluronate (L): Moisturizes, attracts and holds water in the skin;
Sodium PCA: Potent hydrating and moisturizing humectant that is non-irritating;
Niacinamide: Antioxidant that supports moisture retention and improves the appearanceof skin tone and texture.
Benefits:
Exfoliating
Brightening
Antioxidant support
Skin Conditions:
All Acne Types
Hyperpigmentation
Folliculitis
Skin Types:
All Skin Types
Recommended Use:
Shake well before using. Apply 1 pump all over a clean face or affected area.
Ingredients:
Aqua (Water), Hamamelis Virginiana (Witch Hazel) Water, Mandelic Acid (L), Alcohol, Lactic Acid (L), Butylene Glycol, PPG-3 Benzyl Ether Myristate, Alcohol Denat., Niacinamide, Sodium Lactate, Xanthan Gum, Sodium PCA, Sodium Hyaluronate (L), Urea, Phenethyl Alcohol, Caprylyl Glycol, Potassium Sorbate
Additional information
Weight | 1.8 oz |
---|---|
Dimensions | 4.250 × 1.000 × 1.000 in |
Size |
Reviews
There are no reviews yet.